PIRFENIDONE (Esbriet®)

Clinical Indication

For Idiopathic pulmonary fibrosis

Comments

In line with NICE TA 504 (Replaces NICE TA 282)

Date of classification

May 2018

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.